BioSpace News Archive

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf” or the “Company”), a federally regulated manufacturer and distributor of cannabis vapes and oils, announced today the Jamaica Intellectual Property Office has granted Nextleaf a patent for the Company’s foundational process for producing high-purity CBD and THC ingredients.

The global Anxiety Disorder and Depression Treatment Market is forecasted to grow at a rate of 2.4% from USD 16.17 Billion in 2020 to USD 19.53 Billion in 2028. The market is mainly driven by the increasing prevalence of mental health issues and disorders like anxiety disorder and depression.

The Insulin Pumps Market is projected to grow at a rate of 9.30% in terms of value, from 2020 to reach USD 10.25 Billion by 2028.

Increasing prevalence of various chronic and rare diseases, rising number of road accidents, trauma and emergency cases, and growing awareness about the importance of early disease diagnosis are expected to drive global Magnetic Resonance Imaging Systems market growth.

Agendia, Inc., a commercial-stage company focused on improving outcomes for breast cancer patients worldwide by providing physicians and patients with next-generation diagnostic and information solutions to inform optimized treatment decision-making, today announced 10,000 patients have been successfully enrolled in the FLEX Registry.

Code Ocean, the developer of a first-of-its-kind, computational-research laboratory SaaS platform for scientific collaboration and discovery, today announced $16.5 million in Series-B funding co-led by Battery Ventures and M12, Microsoft’s Venture Fund.

Biosenta Inc. is developing environmentally friendly biocidal particles that are successfully tested against infectious bacteria growing on common surfaces.

A new study with TikoMed’s platform lead clinical drug candidate ILB®, provides positive safety and tolerability results and the first clinical evidence of encouraging clinical efficacy of ILB® in the treatment of amyotrophic lateral sclerosis (ALS).

MDxHealth Announces Resultsof its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director

Leidos (NYSE: LDOS), a FORTUNE 500® science and technology leader, will participate in the Jefferies Virtual IT Services Summit.